Managing Crohn Disease in Children and Adolescents: Focus on Tumor Necrosis Factor Antagonists

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.10, Iss.1, 2008-01, pp. : 31-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis

By Ranganathan Prabha

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 481-490

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Crohns Disease

By Shetty A. Forbes A.

American Journal of PharmacoGenomics, Vol. 2, Iss. 4, 2002-01 ,pp. : 215-221

Adis International

Access to resources Recommend Favorite

Is There Any Future for Tumor Necrosis Factor Antagonists in Chronic Heart Failure?

By Arthur M. Feldman

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 1, 2004-01 ,pp. : 11-19

Adis International

Access to resources Recommend Favorite

Failing To Mend A Broken Heart But Still Hope for Tumor Necrosis Factor- Antagonists

By Arthur Feldman Charles Mctiernan

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 3, 2004-06 ,pp. : 8-12

Adis International

Access to resources Recommend Favorite

Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis

By Braun Juergen Baraliakos Xenofon Heldmann Frank Kiltz Uta

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 647-659

Informa Healthcare

Access to resources Recommend Favorite